Kallol Purkait
Overview
Explore the profile of Kallol Purkait including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
56
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang Y, Mesdom P, Purkait K, Saubamea B, Burckel P, Arnoux P, et al.
Chem Sci
. 2023 Nov;
14(42):11749-11760.
PMID: 37920359
Photodynamic therapy (PDT) is a medical technique for the treatment of cancer. It is based on the use of non-toxic molecules, called photosensitizers (PSs), that become toxic when irradiated with...
2.
Enslin L, Purkait K, Dalla Pozza M, Saubamea B, Mesdom P, Visser H, et al.
Inorg Chem
. 2023 Jul;
62(31):12237-12251.
PMID: 37489813
Eight rhenium(I) tricarbonyl aqua complexes with the general formula -[Re(CO)('-bid)(HO)][NO] (), where '-bid is (2,6-dimethoxypyridyl)imidazo[4,5-]1,10-phenanthroline (), (indole)imidazo[4,5-]1,10-phenanthroline (), (5-methoxyindole)-imidazo[4,5-]1,10-phenanthroline (), (biphenyl)imidazo[4,5-]1,10-phenanthroline (), (fluorene)imidazo[4,5-]1,10-phenanthroline (), (benzo[]thiophene)imidazo[4,5-]1,10-phenanthroline (), (5-bromothiazole)imidazo[4,5-]1,10-phenanthroline (), and (4,5-dimethylthiophene)imidazo[4,5-]1,10-phenanthroline...
3.
Chakraborty A, Roy S, Chakraborty M, Roy S, Purkait K, Koley T, et al.
Inorg Chem
. 2021 Nov;
60(23):18379-18394.
PMID: 34780170
Eight new ruthenium(II) complexes of ,-chelating pyrazolylbenzimidazole ligands of the general formula [Ru(-cym)(L)X] [where the ligand L is 2-(1-pyrazol-1-yl)-1-benzo[]imidazole () substituted at the 4 position of the pyrazole ring by...
4.
Gandioso A, Purkait K, Gasser G
Chimia (Aarau)
. 2021 Nov;
75(10):845-855.
PMID: 34728011
Photodynamic therapy (PDT) is a remarkable alternative or complementary technique to chemotherapy, radiotherapy or immunotherapy to treat certain forms of cancer. The synergistic effect of light, photosensitizer (PS) and oxygen...
5.
Mukherjee A, Koley T, Chakraborty A, Purkait K, Mukherjee A
Chem Asian J
. 2021 Sep;
16(22):3729-3742.
PMID: 34549886
Half-sandwich Ru complexes, [(YZ)Ru (η -arene)(X)]+, (YZ=chelating bidentate ligand, X=halide), with N,N and N,O coordination (1-9) show significant antiproliferative activity against the metastatic triple-negative breast carcinoma (MDA-MB-231). 3-aminobenzoic acid or...
6.
Chatterjee R, Bhattacharya I, Roy S, Purkait K, Koley T, Gupta A, et al.
Inorg Chem
. 2021 Aug;
60(16):12172-12185.
PMID: 34346215
Morpholine motif is an important pharmacophore and, depending on the molecular design, may localize in cellular acidic vesicles. To understand the importance of the presence of pendant morpholine in a...
7.
Maji M, Acharya S, Maji S, Purkait K, Gupta A, Mukherjee A
Inorg Chem
. 2020 Jun;
59(14):10262-10274.
PMID: 32585099
We report [Ru(L)(η--cym)Cl] ( and ) and [Pt(L)(DMSO)Cl] ( and ) complexes, where L is a chelate imine ligand derived from chloroethylamine and salicylaldehyde () or o-vanillin (). The complexes...
8.
Mukherjee A, Acharya S, Purkait K, Chakraborty K, Bhattacharjee A, Mukherjee A
Inorg Chem
. 2020 Apr;
59(9):6581-6594.
PMID: 32295347
Ruthenium compounds are promising anticancer candidates owing to their lower side-effects and encouraging activities against resistant tumors. Half-sandwich piano-stool type Ru compounds of general formula [(L)Ru(η-arene)(X)] (L = chelating bidentate...
9.
Karmakar S, Chatterjee S, Purkait K, Mukherjee A
J Inorg Biochem
. 2020 Jan;
204:110982.
PMID: 31911365
A trans-dichloridoplatinum(II) complex, trans-[PtCl(L)(DMSO)] (1) of a monodentate nitrogen mustard, bis(2-chloroethyl)amine (L), was synthesized by the reaction of cis-[PtCl(DMSO)] &L.HCl in presence of EtN. 1 was characterised by NMR, FT-IR...
10.
Purkait K, Ruturaj , Mukherjee A, Gupta A
Inorg Chem
. 2019 Oct;
58(22):15659-15670.
PMID: 31657924
Ruthenium(II/III) complexes are predicted to be efficient alternatives to platinum drug-resistant cancers but have never been investigated for sequestration and efflux by Cu-ATPases (ATP7A or ATP7B) overexpressed in resistant cancer...